Evidence map›Paper›PMID 16680902›Full record

ArticleThe Journal of allergy and clinical immunology2006

Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005.

Luigi Notarangelo, Jean-Laurent Casanova, Mary Ellen Conley, Helen Chapel, Alain Fischer, Jennifer Puck, Chaim Roifman, Reinhard Seger, Raif S Geha, International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee

Abstract readConference Proceedings
PubMed Publisher
In one paragraph

Article in The Journal of allergy and clinical immunology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Immune Sexual Dimorphism: Connecting the Dots.Physiology (Bethesda, Md.) · 2022
    Review
  8. Review
  9. Review
  10. Review
  11. STAT3 gain-of-function mutation in a patient with pulmonaryRespiratory medicine case reports · 2020
    Article
  12. A Case Report ofGlobal pediatric health · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Luigi NotarangeloDepartment of Pediatrics, University of Brescia Spedali Civili, Italy.
Jean-Laurent Casanova
Mary Ellen Conley
Helen Chapel
Alain Fischer
Jennifer Puck
Chaim Roifman
Reinhard Seger
Raif S Geha
International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee

Funding

TRANSGENIC MODELS OF T CELL RECEPTOR IMMUNODEFICIENCIESP01AI035714 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TERHORST, CORNELIS P · 1994 to 2007
$9.3M
NIAID NIH HHS AI-35714
6 · The paper itself

Abstract

Although relatively rare, primary immunodeficiency diseases (PIDs) provide an excellent window into the functioning of the immune system. In the late 1960s, observations on these diseases, with their associated infections and genetics, bisected the immune system into humoral immunity and cell-mediated immunity. These diseases also represent a challenge in their diagnosis and treatment. Beginning in 1970, a unified nomenclature for the then-known PIDs was created by a committee convoked by the World Health Organization. Since then, and later under the aegis of the International Union of Immunological Societies, an international committee of experts has met every 2 to 3 years to update the classification of PIDs. During the past 15 years, the molecular basis of more than 120 PIDs has been elucidated. This update results from the latest meeting of this committee in Budapest, Hungary, in June 2005, which followed 2 1/2 days of scientific discussions. As a result of this work, new entities have been included, and the nomenclature of some PIDs (specifically of the various forms of class-switch recombination defects, previously known as hyper-IgM syndromes) has been changed.

Indexed as

B-LymphocytesComplement System ProteinsHumansHungaryImmunity, InnateImmunologic Deficiency SyndromesPhagocytesTerminology as TopicT-LymphocytesComplement System Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.